FDA Inspection 1002801 — Advancing Sight Network Southeast Regional Office

Advancing Sight Network Southeast Regional Office — FEI 3003562222

The FDA completed an inspection of Advancing Sight Network Southeast Regional Office on December 7, 2016 in Montgomery, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 7, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Montgomery, AL (United States)